BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Treatment
16 results:

  • 1. Primary Ntrk -rearranged Spindle Cell Neoplasm of the Gastrointestinal Tract: A Clinicopathological and Molecular Analysis of 8 Cases.
    Gao X; Xu S; Zhu P; Lao IW; Yu L; Wang J
    Am J Surg Pathol; 2024 May; 48(5):623-631. PubMed ID: 38525823
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A novel c-Met/trk inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation.
    An B; Nie W; Hu J; Fan Y; Nie H; Wang M; Zhao Y; Yao H; Ren Y; Zhang C; Wei M; Li W; Liu J; Yang C; Zhang Y; Li X; Tian G
    Cell Death Dis; 2023 Nov; 14(11):728. PubMed ID: 37945598
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [
    Günther T; Holzleitner N; Viering O; Beck R; Wienand G; Dierks A; Pfob CH; Bundschuh RA; Kircher M; Lapa C; Wester HJ
    J Nucl Med; 2024 Jan; 65(1):33-39. PubMed ID: 37945383
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinicopathological features of gastric carcinomas with Ntrk-rearrangement/amplification: report of four cases].
    Xu AD; Fu Y; Pu XH; Wu HY; Sun Q; Fan XS
    Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):454-459. PubMed ID: 37106286
    [No Abstract]    [Full Text] [Related]  

  • 5. Selpercatinib treatment of RET-Mutated Thyroid cancers Is Associated With Gastrointestinal Adverse Effects.
    Tsang V; Gill A; Gild M; Lurie B; Blumer L; Siddall R; Clifton-Bligh R; Robinson B
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3824-e3829. PubMed ID: 35647935
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Entrectinib Induces Apoptosis and Inhibits the Epithelial-Mesenchymal Transition in gastric cancer with Ntrk Overexpression.
    Sohn SH; Sul HJ; Kim BJ; Kim HS; Zang DY
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008821
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Gastropharyngeal Anastomotic Leak in Medullary Thyroid Carcinoma Following Initiation of a Tyrosine Kinase Inhibitor: A Case Report of an Unusual Side Effect of Cabozantinib.
    Ackerman J; Kent S; Walker P
    Ann Otol Rhinol Laryngol; 2020 Jul; 129(7):657-661. PubMed ID: 32037846
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Analysis of Ntrk expression in gastric and esophageal adenocarcinoma (AGE) with pan-trk immunohistochemistry.
    Arnold A; Daum S; von Winterfeld M; Berg E; Hummel M; Horst D; Rau B; Stein U; Treese C
    Pathol Res Pract; 2019 Nov; 215(11):152662. PubMed ID: 31575452
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cholecystokinin 2 Receptor Agonist
    Rottenburger C; Nicolas GP; McDougall L; Kaul F; Cachovan M; Vija AH; Schibli R; Geistlich S; Schumann A; Rau T; Glatz K; Behe M; Christ ER; Wild D
    J Nucl Med; 2020 Apr; 61(4):520-526. PubMed ID: 31519804
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases.
    Hilberg F; Tontsch-Grunt U; Baum A; Le AT; Doebele RC; Lieb S; Gianni D; Voss T; Garin-Chesa P; Haslinger C; Kraut N
    J Pharmacol Exp Ther; 2018 Mar; 364(3):494-503. PubMed ID: 29263244
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs.
    Kita K; Arai S; Nishiyama A; Taniguchi H; Fukuda K; Wang R; Yamada T; Takeuchi S; Tange S; Tajima A; Nakada M; Yasumoto K; Motoo Y; Murakami T; Yano S
    Cancer Med; 2017 Dec; 6(12):2972-2983. PubMed ID: 29125233
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel multiple tyrosine-kinase targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple solid tumors: cabozantinib.
    Roy S; Narang BK; Rastogi SK; Rawal RK
    Anticancer Agents Med Chem; 2015; 15(1):37-47. PubMed ID: 25181996
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. K252a inhibits the oncogenic properties of Met, the HGF receptor.
    Morotti A; Mila S; Accornero P; Tagliabue E; Ponzetto C
    Oncogene; 2002 Jul; 21(32):4885-93. PubMed ID: 12118367
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Complication of reservoir hepatic artery infusion chemotherapy and additional treatments].
    Niinobu T; Shibata T; Shibata N; Takada T; Kitada M; Tsukahara Y; Iihara K; Ikeda K; Ogawa M; Hayashi N; Takami M; Ishida T
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1843-7. PubMed ID: 9382547
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Long-term survival in two cases of multiple liver metastasis successfully treated with intraoperative ultrasound-guided microwave tumor coagulation (mtc)].
    Ogawa M; Shibata T; Takami M; Tsujinaka T; Takada T; Kitada M; Tsukahara Y; Murotani M; Niinobu T; Iihara K
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1679-83. PubMed ID: 7574791
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast cancer Study Group.
    Rutqvist LE; Johansson H; Signomklao T; Johansson U; Fornander T; Wilking N
    J Natl Cancer Inst; 1995 May; 87(9):645-51. PubMed ID: 7752269
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.